FDA Encouraged Illegal Compounding, K-V Tells DC Circ.
Bankrupt drugmaker K-V Pharmaceutical Co. on Friday urged a D.C. Circuit panel to prevent the U.S. Food and Drug Administration from allowing unapproved compounding ingredients into the country that are used...To view the full article, register now.
Already a subscriber? Click here to view full article